President's Budget Repeats Call For Seven Years Of Biologics Exclusivity

The fiscal year 2017 budget proposal submitted by the Obama administration on Tuesday (Feb. 9) reiterated its proposal from previous years to roll back the term of market exclusivity for biologics under U.S. law to seven years from the current 12 years, which would be one year less than what the administration claims is required under the Trans-Pacific Partnership (TPP). The proposal to reduce the term to seven years is one of three previously proposed reforms in the budget “designed...